ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
741 |
261K |
11 |
06/08/24 |
06/08/24 |
ASX - By Stock
|
741
|
261K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
741 |
261K |
8 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
741
|
261K
|
8
|
|
ASX - By Stock
|
APX |
Re:
The Journey of Appen’s Stock Price and Business Operations Through Recent Years
|
|
bedger
|
452 |
172K |
3 |
05/08/24 |
05/08/24 |
ASX - By Stock
|
452
|
172K
|
3
|
|
ASX - By Stock
|
CYP |
Re:
Stem Cell News
|
|
bedger
|
519 |
130K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
519
|
130K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
bedger
|
18K |
7.2M |
17 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
18K
|
7.2M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
bedger
|
385 |
184K |
2 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
385
|
184K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
30K |
6 |
02/08/24 |
02/08/24 |
ASX - By Stock
|
142
|
30K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
30K |
7 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
30K
|
7
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
30K |
3 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
30K
|
3
|
|
ASX - By Stock
|
ZIP |
Re:
$1.50 SOON
|
|
bedger
|
142 |
30K |
6 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
142
|
30K
|
6
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
2.9K |
759K |
15 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
2.9K
|
759K
|
15
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
456 |
171K |
4 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
456
|
171K
|
4
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
2.9K |
759K |
17 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
2.9K
|
759K
|
17
|
|
ASX - By Stock
|
OCC |
Re:
OCC Trading
|
|
bedger
|
1.8K |
573K |
11 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
1.8K
|
573K
|
11
|
|
ASX - By Stock
|
ZIP |
Re:
$3 Party
|
|
bedger
|
2.9K |
759K |
17 |
01/08/24 |
01/08/24 |
ASX - By Stock
|
2.9K
|
759K
|
17
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
13K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
13K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Activities Update Qtr Ending June 2024 and Appendix 4C
|
|
bedger
|
30 |
13K |
2 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
30
|
13K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
In Kiwi land we eagerly await "The bedger Report" on Zip
|
|
bedger
|
23 |
5.1K |
13 |
31/07/24 |
31/07/24 |
ASX - By Stock
|
23
|
5.1K
|
13
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
456 |
171K |
18 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
456
|
171K
|
18
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
456 |
171K |
1 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
456
|
171K
|
1
|
|
ASX - By Stock
|
APX |
Re:
Ann: Q2 FY24 Quarterly Activity Report and Appendix 4C
|
|
bedger
|
456 |
171K |
8 |
30/07/24 |
30/07/24 |
ASX - By Stock
|
456
|
171K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
bedger
|
12K |
4.0M |
35 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
12K
|
4.0M
|
35
|
|
ASX - By Stock
|
ZIP |
Re:
ZIP's coming 1Q FY24 Trading Update
|
|
bedger
|
275 |
58K |
15 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
275
|
58K
|
15
|
|
ASX - By Stock
|
ZIP |
Re:
ZIP's coming 1Q FY24 Trading Update
|
|
bedger
|
275 |
58K |
11 |
29/07/24 |
29/07/24 |
ASX - By Stock
|
275
|
58K
|
11
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
4 |
26/07/24 |
26/07/24 |
ASX - By Stock
|
66
|
23K
|
4
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
741 |
261K |
17 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
741
|
261K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Sharewise Presentation 22/7/24
|
|
bedger
|
139 |
43K |
26 |
25/07/24 |
25/07/24 |
ASX - By Stock
|
139
|
43K
|
26
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
bedger
|
3.5K |
1.3M |
11 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
3.5K
|
1.3M
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Global Market Expansion Accelerates - New Regions Pending
|
|
bedger
|
18 |
5.6K |
18 |
24/07/24 |
24/07/24 |
ASX - By Stock
|
18
|
5.6K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
bedger
|
385 |
184K |
2 |
23/07/24 |
23/07/24 |
ASX - By Stock
|
385
|
184K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.7K |
841K |
9 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
3.7K
|
841K
|
9
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.7K |
841K |
8 |
19/07/24 |
19/07/24 |
ASX - By Stock
|
3.7K
|
841K
|
8
|
|
ASX - By Stock
|
ZIP |
Re:
The Bear Room
|
|
bedger
|
3.7K |
841K |
11 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
3.7K
|
841K
|
11
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
23K
|
2
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
bedger
|
28 |
10K |
24 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
28
|
10K
|
24
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
3 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
23K
|
3
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
2 |
18/07/24 |
18/07/24 |
ASX - By Stock
|
66
|
23K
|
2
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
6 |
17/07/24 |
17/07/24 |
ASX - By Stock
|
66
|
23K
|
6
|
|
ASX - By Stock
|
OSX |
Re:
Ann: Osteopore strikes Exclusive Distribution with Zimmer Biomet
|
|
bedger
|
66 |
23K |
3 |
16/07/24 |
16/07/24 |
ASX - By Stock
|
66
|
23K
|
3
|
|
ASX - By Stock
|
HAS |
Re:
Ann: JL MAG to Become 9.8% Strategic Investor in Hastings
|
|
bedger
|
27 |
16K |
7 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
27
|
16K
|
7
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
bedger
|
34 |
9.5K |
5 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.5K
|
5
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Trading Halt
|
|
bedger
|
34 |
9.5K |
22 |
10/07/24 |
10/07/24 |
ASX - By Stock
|
34
|
9.5K
|
22
|
|
ASX - By Stock
|
OCC |
Re:
Ann: Record Quarterly and Yearly Revenue Show Outstanding Growth
|
|
bedger
|
34 |
8.6K |
11 |
09/07/24 |
09/07/24 |
ASX - By Stock
|
34
|
8.6K
|
11
|
|
ASX - By Stock
|
OCC |
Re:
Media thread
|
|
bedger
|
741 |
261K |
17 |
08/07/24 |
08/07/24 |
ASX - By Stock
|
741
|
261K
|
17
|
|
ASX - By Stock
|
PAR |
Re:
Where we at?
|
|
bedger
|
706 |
262K |
4 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
706
|
262K
|
4
|
|
ASX - By Stock
|
ARU |
Re:
Ann: Arafura confirms German ECA support with Euler Hermes
|
|
bedger
|
34 |
17K |
6 |
04/07/24 |
04/07/24 |
ASX - By Stock
|
34
|
17K
|
6
|
|
ASX - By Stock
|
CYP |
Re:
Ann: Cynata to Acquire IP from Tekcyte
|
|
bedger
|
73 |
17K |
7 |
01/07/24 |
01/07/24 |
ASX - By Stock
|
73
|
17K
|
7
|
|
ASX - By Stock
|
ARU |
Re:
Arafura Rare Earths Ltd
|
|
bedger
|
1.4K |
643K |
14 |
28/06/24 |
28/06/24 |
ASX - By Stock
|
1.4K
|
643K
|
14
|
|
ASX - By Stock
|
ASM |
Re:
Relevant Media
|
|
bedger
|
3.5K |
1.3M |
5 |
27/06/24 |
27/06/24 |
ASX - By Stock
|
3.5K
|
1.3M
|
5
|
|